First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia

Prenatal Diagnosis

Volumn 31, Issue 10, 2011, Pages 955-961

  Vandenberghe, G ^a,c   Mensink, I ^a   Twisk, J W R ^a   Blankenstein, M A ^a   Heijboer, A C ^a   van Vugt, J M G ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Intra uterine growth restriction; Placental growth factor; Pre eclampsia; Pregnancy associated plasma protein A; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; THYROXINE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MEAN ARTERIAL PRESSURE; MEDICAL HISTORY; PARITY; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREECLAMPSIA; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; MASS SCREENING; NETHERLANDS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 80053333871     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2807     Document Type: Article

References (36)

1. Akolekar R, Zaragoza E, Poon LCY, Pepes S, Nicolaides KH. 2008. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 32(6): 732-739.
2. Cowans NJ, Spencer K. 2007. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27(3): 264-271.
3. Cowans NJ, Stamatopoulou A, Matwejew E, et al. 2010. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn 30: 565-570.
4. Crispi F, Dominguez C, Llurba E, et al. 2006. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195: 201-207.
5. Crispi F, Llurba E, Dominguez C, et al. 2008. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 31: 303-309.
6. Davey DA, MacGillivray I. 1988. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158: 892-898.
7. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191: 1446-1451.
8. Erez O, Romero R, Esinoza J, et al. 2008. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 21: 279-287.
9. Goetzinger KR, Singla A, Gerkowicz S, et al. 2009. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 201: 412.e1-412.e6.
10. Kagan KO, Wright D, Baker A, et al. 2008. Screening for trisomy 21 by maternal age, fetal NT, free β hCG and PAPP-A. Ultrasound Obstet Gynecol 31: 618-624.
11. Krauss T, Pauer HU, Augustin HG. 2004. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 23: 101-111.
12. Levine RJ, Maynard SE, Qian C, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683.
13. Linskens IH, Spreeuwenberg MD, Blankenstein MA, van Vugt JM. 2009. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn 29: 74-78.
14. Ong CY, Liao AW, Spencer K, et al. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynecol 107: 1265-1270.
15. Ong CY, Liao AW, Cacho AM, et al. 2001. First trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 98: 608-611.
16. Pilalis A, Souka AP, Antsaklis P, et al. 2007. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks gestation. Ultrasound Obstet Gynecol 29: 135-140.
17. Polliotti BM, Fry AG, Saller DN, et al. 2003. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 101: 1266-1274.
18. Poon LCY, Zaragoza E, Akolekar R, et al. 2008. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) tot 13(+16) weeks of gestation. Prenat Diagn 228: 1110-1115.
19. Poon LCY, Maiz N, Valencia C, et al. 2009a. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
20. Poon LCY, Kametas NA, Maiz N, et al. 2009b. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 53: 812-818.
21. Poon LCY, Stratieva V, Piras S, et al. 2010a. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn 30: 216-223.
22. Poon LCY, Akolekar R, Lachmann R, et al. 2010b. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 35: 662-670.
23. Robinson CJ, Johnson DD, Chang EY, et al. 2006. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 195: 255-259. Epub 2006 April 21.
24. Romero R, Nien JK, Espinoza J, et al. 2008. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-a) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21: 9-23.
25. Sibai BM, Koch MA, Freire S, et al. 2008. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 199: 268.e1-268.e9.
26. Smith GC, Stenhouse EJ, Crossley JA, et al. 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87: 1762-1727.
27. Smith GC, Shah I, Crossley JA, et al. 2006. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107: 161-166.
28. Smith GCS, Crossley JA, Aitken DA, et al. 2007. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 109: 1316-1324.
29. Spencer K, Yu CKH, Cowans NJ, et al2005. Prediction of pregnancy complications by first trimester maternal serum PAPP-A and free β-hCG and with second trimester uterine artery Doppler. Prenat Diagn 25: 949-953.
30. Spencer K, Cowans NJ, Chefetz I, et al. 2007. First trimester maternal serum PP-13, PAPP-A and second trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 29: 128-134.
31. Su YN, Lee CN, Cheng WF, et al. 2001. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 97: 898-904.
32. Taylor RN, Grimwood J, Taylor RS, et al. 2003. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188: 177-182.
33. Thadhani R, Mutter WP, Wolf M, et al. 2004. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89: 770-775.
34. Tidwell SC, Ho HN, Chiu WH, et al. 2001. Low maternal serum levels of placenta growth facor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184: 1267-1272.
35. Widmer M, Villar J, Benigni A, et al. 2007. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 109: 168-180.
36. Yaron Y, Heifetz S, Ochshorn Y, et al. 2002. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 22: 778-782.